The Value of HPV Detection - Testing, biomarkers, serology and genomics: revisiting the progress and practices (Part I)
Wednesday, June 15, 2016
Main Training Course
•
MTC 03 I
•
1:45 PM
>
3:50 PM
•
The Value of HPV Detection - Testing, biomarkers, serology and genomics: revisiting the progress and practices (Part I)
•
Europa Hall
Main Training Course
•
MTC 03 I-01
•
HPV assays for research and clinical practices: which test for which uses
>
L.
Laia
Alemany
•
MTC 03 I-02
•
Performance by sites: Cervix vs H&N
>
P.
Peter
Snijders
•
MTC 03 I-04
•
Practical uses: Lab / pathologists vs onsite outpatient clinic
See abstract
>
J.
Jack
Cuzick
•
MTC 03 I-06
•
Molecular Markers and new approaches to stratifying disease risk in cervical screening
See abstract
>
E.
Evangelos
Paraskevaidis
•
MTC 03 I-08
•
Cytologic triage of HPV positive women
See abstract
>
G.
Guglielmo
Ronco
•
MTC 03 I-09
•
Options for triage of women with positive cervical HPV tests
See abstract
>
W.
Walter
Kinney
•
MTC 03 I-07
•
WHICH HPV ASSAYS FULFILL REQUIREMENTS FOR CERVICAL CANCER SCREENING
See abstract
>
M.
Marc
Arbyn
•
MTC 03 I-03
•
FEASIBILITY AND COST IMPLICATIONS OF INTRODUCING HPV ASSAYS IN LOW AND MIDDLE INCOME COUNTRIES (LMIC) COMPARED WITH HIGH INCOME COUNTRIES (HIC)
See abstract
>
H.
Heather
Cubie
•
MTC 03 I-05
•
E. Validation methods, quality assurance and transport media
See abstract
>
J.
Joakim
Dillner
•
MTC 03 I-10
•
THE CHALLENGES ASSOCIATED WITH SCREENING VACCINATED WOMEN
See abstract
>
K.
Kate
Cuschieri
|